Rna replicon for improving gene expression and use thereof
AssigneeSouth China University of Technology
InventorsYuan ZHANG, Guibin LIN
Life of this patent
Estimating the term…
Loading patent…
AssigneeSouth China University of Technology
InventorsYuan ZHANG, Guibin LIN
Estimating the term…
Disclosed in the present invention are an RNA replicon for improving gene expression, and a use thereof. The RNA replicon comprises: 5′ and 3′ untranslated regions; a non-structural protein gene coding region, a subgenomic promoter and a target gene coding region. In the present invention, a PCR site-directed mutagenesis technique is used to introduce the non-structural protein region mutant replicable RNA, which is transfected into mammalian eukaryotic cells by means of Lipofectamine 2000 or nanoparticles, so as to significantly enhance the expression of cytokines and chemokines including GM-CSF, IFN-γ, IL-2, IL-12, IL-15 mediated by downstream subgenomic promoters, and can be applied to treatment of tumors, infectious diseases, autoimmune diseases, hereditary diseases or cardiovascular diseases.
An RNA replicon, comprising in a 5′ to 3′ direction:
Dependencies are inferred from the claim text.